Grant: Doctoral Research Award: Canada Graduate Scholarships
McMaster University
$105,000.00
Integrating Interpretable Machine Learning, Multiomics, and Systemic Vascular Imaging to Predict Mortality from Cardiometabolic Diseases
FY 2023-24
Summary
High deaths rates from diabetes, heart attacks, and strokes are overwhelming healthcare services worldwide. We urgently need rapid, accurate, low-cost, and clear technology to determine a person's mortality risk from these conditions. To support healthcare decision making, we aim to leverage a massive dataset of eye images and blood samples from over 25,000 Canadian participants to identify causal predictive markers of disease mortality. To achieve this, we are pioneering technology to quantify blood vessel health from eye images, which indicates the health of all organs and has been associated with mortality, and combines it with small details like genetics and proteins. Overall, this study proposes a new technology to prioritize those at the highest risk of dying, potentially reducing the death rate.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
496464
Name
Kadem Mason
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Integrating Interpretable Machine Learning, Multiomics, and Systemic Vascular Imaging to Predict Mortality from Cardiometabolic Diseases
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cardiometabolic Diseases; Genetics; Interpretability; Machine Learning; Microvasculature; Mortality; Multiomics; Retinal Imaging; Risk Prediction
Abstract
High deaths rates from diabetes, heart attacks, and strokes are overwhelming healthcare services worldwide. We urgently need rapid, accurate, low-cost, and clear technology to determine a person's mortality risk from these conditions. To support healthcare decision making, we aim to leverage a massive dataset of eye images and blood samples from over 25,000 Canadian participants to identify causal predictive markers of disease mortality. To achieve this, we are pioneering technology to quantify blood vessel health from eye images, which indicates the health of all organs and has been associated with mortality, and combines it with small details like genetics and proteins. Overall, this study proposes a new technology to prioritize those at the highest risk of dying, potentially reducing the death rate.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kadem, Mason
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~